Metoprolol Tartrate Tablets Recalled for Metal Wire Contamination
Aurobindo Pharma USA Inc. is recalling Metoprolol Tartrate 100 mg tablets due to the presence of metal wire found in at least one tablet. The FDA classified this as a Class II recall affecting 2,820 bottles distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving a risk-of-harm hazard (metal wire contamination in a critical cardiac medication). Although no illnesses or injuries have been reported, the presence of a foreign object in a prescription drug that cannot be visually detected by patients creates significant potential for patient injury. Class II recalls require a score of at least 3, and the nature of this hazard (physical contamination in a heart medication) justifies a High severity rating.
Plain-English summary
Aurobindo Pharma USA Inc. is recalling Metoprolol Tartrate Tablets USP 100 mg (1,000-count bottles) distributed nationwide in the United States. The recall was initiated after product complaints identified the presence of metal wire in one tablet.
The affected product is Lot MJ1019025-A with an expiration date of 04/2022, distributed under NDC 65862-064-99. A total of 2,820 bottles have been distributed.
Metoprolol tartrate is a prescription medication used to treat heart conditions. Consumers who have this product should stop taking it and contact their pharmacist or healthcare provider. Patients should not discontinue their heart medication without medical guidance; they should consult their doctor about obtaining unaffected product or alternative treatment options.
Healthcare providers and pharmacists should check their inventory for the affected lot and quarantine any remaining stock. Consumers with questions can contact Aurobindo Pharma USA Inc. at 279 Princeton-Highstown Road East Windsor, NJ 08520.
The recalled product
- Product
- METOPROLOL TARTRATE (METOPROLOL TARTRATE)
- Brand
- METOPROLOL TARTRATE
- Manufacturer
- Aurobindo Pharma USA Inc.
- Hazard
- metal-contamination
- foreign-object
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: MJ1019025-A
- Exp. date 04/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METOPROLOL TARTRATE
- HighMetoprolol Tartrate Tablets Recalled for Nitrosamine Contamination Above Safety Limits
FDA (Drugs) · 2025-08-20
- HighMetoprolol Tartrate Tablets Recalled for Nitrosamine Contamination Above Safety Limits
FDA (Drugs) · 2025-08-20
- HighMetoprolol Tartrate Tablets Recalled Nationwide for Metal Contamination
FDA (Drugs) · 2024-06-05
- HighMetoprolol Tartrate Tablets Recalled for Foreign Metal in Tablets
FDA (Drugs) · 2022-01-19
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27